Scotmas Secures $2.2M Funding to Revolutionize Water Treatment with Innovative Chlorine Dioxide Solutions

Scotmas Group is thrilled to announce a new chapter of growth and innovation as we secure £2,200,000 in funding. This significant investment underscores not only investor confidence in our groundbreaking Chlorine Dioxide products and dosing systems but also recognizes our ongoing commitment to advancing optimal disinfection and water treatment solutions. As the leading manufacturer in this space, Scotmas has built its reputation by developing environmentally friendly alternatives that effectively eliminate dangerous pathogens, including Legionella, while being a safe substitute for toxic biocides. This funding will drive the expansion of our innovative product lineup, including our highly acclaimed Cidox™ Chlorine Dioxide disinfection tablets and AbScent™ odour control sachets, as well as further development within our versatile chlorine dioxide generators like the Alpha™. The infusion of capital is earmarked to bolster research and development, improve production capabilities, and widen our distribution channels both domestically and internationally from our headquarters in Scotland, UK. Enhanced R&D initiatives will allow us to tailor new dosing systems for a growing range of applications—from small-scale agricultural implementations to custom-designed solutions for water treatment and offshore oil installations. As we continue to meet the highest Global Health & Safety Standards, our experienced team of engineers and technicians is excited to leverage these funds to push technological boundaries and deliver reliable, user-friendly water treatment solutions to businesses of all sizes. This is an exciting time for Scotmas, and we invite our partners, customers, and industry stakeholders to join us on this transformative journey toward safer, cleaner water globally.